Trust & Security Centre
How Lazomis QI protects your information
Lazomis QI is designed for non-identifiable clinical audit and quality-improvement information. It must not be used to store patient-identifiable information.
Organisational requirements vary. Healthcare professionals should follow their employer’s procedures for registering audits, approving quality-improvement work and using external digital platforms.
Lazomis QI is operated by Flux Medical Limited, which is registered with the Information Commissioner’s Office. Lazomis QI does not sell users’ clinical audit information.
Non-identifiable by design
No patient names, NHS numbers or hospital numbers are needed to run a project.
Controlled access
Encrypted connections, authenticated accounts and role-based project access.
Your policies still apply
Local audit registration and information-governance requirements remain with you.
At a glance
- Lazomis QI is designed for anonymised clinical audit and quality-improvement data.
- Patient-identifiable information must not be entered. Local approval does not override this.
- Local audit registration and your organisation’s requirements still apply.
- Hosted on secure cloud infrastructure in the UK and EU; encrypted connections, authenticated accounts and server-enforced, role-based project access.
- AI features assist with drafting and summarising, and every output is reviewed by the user. Provider arrangements are available through direct discussion.
- Flux Medical Limited is registered with the ICO and has completed and published a Data Security and Protection Toolkit submission.
- Organisations can discuss governance and security directly with Lazomis using the contact route on this page.
Using the platform safely
What information can be entered into Lazomis QI?
What information must never be entered?
Does Lazomis QI require patient-identifiable information?
Is pseudonymised information the same as anonymous information?
Can I use Lazomis QI without organisational approval?
Who is responsible for registering or approving an audit locally?
How information is handled
Where is information hosted?
How is information protected?
Who can access project information?
Does Lazomis sell clinical audit information?
Is information used to train public AI models?
How long is information retained?
Can a user delete a project or account?
What happens if an account or security incident is suspected?
Registration, assurance and contact
Is Flux Medical Limited registered with the ICO?
What is the status of the Data Security and Protection Toolkit?
What is the status of DTAC assessment?
What information can be discussed with organisations considering the platform?
How can an audit, governance, data-protection or information-governance team contact Lazomis?
Where can users find the Privacy Policy and other existing governance or security information?
Information for organisations
Healthcare organisations may need to review Lazomis QI before approving organisation-wide use. Supporting information about the platform, its intended data boundary and relevant safeguards is available through direct discussion with Lazomis.
We can discuss the information required to support local data-protection, information-governance, clinical-safety and digital-technology assessments.
This page complements, and does not replace, our Privacy Policy, Terms of Use and Governance & Security information.